R&D Tax Credit Israel: A Founder's Guide to Hok Ha'idud

Israel's R&D tax incentives are among the most generous in the world, but the rules — split across the Encouragement of Capital Investments Law ("Hok Ha'idud"), the Innovation Authority grants, and ITA rulings — confuse most founders. This guide walks Israeli tech startups through eligibility, the application process, and what to prepare before you file.

What is Hok Ha'idud?

The Encouragement of Capital Investments Law grants reduced corporate tax rates and dividend withholding rates to qualifying technology companies. The two regimes most relevant to startups are:

• Preferred Technology Enterprise (PTE) — corporate tax of 12% (or 7.5% in Development Area A) on qualifying tech income.
• Special Preferred Technology Enterprise (SPTE) — corporate tax of 6% for very large groups (consolidated revenue ≥ NIS 10B).

Most venture-backed startups qualify under PTE once they generate qualifying income from software, IP licensing, or tech services.

Eligibility Requirements

To claim PTE benefits, your company must satisfy *all* of the following:

1. R&D intensity — at least 7% of revenue spent on R&D over the prior three years (or annual R&D spend exceeding NIS 75M).
2. Qualifying technology income — revenue derived from software, IP, or qualifying tech services owned and developed in Israel.
3. Israeli IP ownership — the underlying IP must be owned by the Israeli entity (not transferred to a US parent before the benefit period).
4. One of the innovation tests:

• 20%+ of employees in R&D roles, or
• VC investment of at least NIS 8M into the company, or
• Average annual revenue growth of 25%+ over three years, or
• Average annual employee growth of 25%+ over three years.

Israeli founders running a Delaware C-Corp with an Israeli subsidiary need to be especially careful: if the IP sits in the US parent, you generally cannot claim PTE benefits on that revenue. Plan IP ownership *before* you scale.

Application Process

Hok Ha'idud benefits are self-assessed — there is no pre-approval. The process looks like this:

1. Document R&D activity throughout the year: time tracking by employee, project descriptions, technical milestones.
2. Tag qualifying income in your accounting system separately from non-qualifying revenue.
3. Prepare a position paper with your tax advisor establishing why each test is met.
4. File the annual corporate tax return (Form 1214) claiming the reduced rate, attaching the supporting schedules.
5. Defend on audit — the ITA frequently challenges classification; your contemporaneous documentation is what wins or loses the position.

For dividend distributions, the reduced 20% withholding (or 4% to a foreign corporate shareholder owning ≥90%) requires a separate ITA ruling in many cases.

Innovation Authority Grants vs. Tax Benefits

Don't confuse the two:

• Innovation Authority (IIA) grants are direct cash funding for R&D projects, repaid via royalties on resulting revenue. They do not reduce corporate tax.
• Hok Ha'idud reduces the tax rate on tech income — independent of whether you took IIA grants.

You can stack both, but IIA grants come with IP residency restrictions: transferring grant-funded IP out of Israel triggers a redemption fee that can reach 6x the grant amount.

Common Pitfalls

• Transferring IP to a US parent post-funding — kills the PTE benefit on related revenue.
• Mixing qualifying and non-qualifying income without segmentation in the books.
• Missing the R&D intensity threshold in years with a revenue spike but flat R&D headcount.
• Forgetting transfer pricing — intercompany services with a US sub need a contemporaneous transfer pricing study, or the ITA can recharacterize the income.
• Late-stage M&A surprises — an acquirer's diligence team will price in lost benefits if your PTE position is weak.

What to Prepare Now

Even pre-revenue startups should set up the foundations:

• A time tracking system that tags hours to R&D projects.
• A chart of accounts that separates qualifying tech revenue from services and resale.
• An IP ownership memo confirming Israeli entity ownership.
• A transfer pricing policy if you have or plan a foreign subsidiary.

When you eventually claim PTE, the documentation you built in years 1–2 is what makes the position defensible.

Bottom Line

R&D tax credits in Israel can take your effective tax rate from 23% to 12% (or 7.5% in Development Area A) — a multi-million-shekel difference at scale. But the benefit is only as strong as the documentation behind it. Start the structure early, and revisit it before any cross-border IP move.

If you want a review of your PTE eligibility and IP ownership structure, reach out to Aleph Accounting — we work with Israeli founders on US-Israel cross-border tax planning every day.